Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
Submitted by
admin
on October 30, 2013 - 11:59am
Source:
TheStreet.com
News Tags:
Endocyte
Europe
ovarian cancer
vintafolide
Headline:
Odds Favor Endocyte Receiving European Approval For Ovarian Cancer Drug
Do Not Allow Advertisers to Use My Personal information
